Evolus Strategic Advantage and Growth slide image

Evolus Strategic Advantage and Growth

LOVVOLUS Qu TARGET MARKET: MILLENNIAL CONSUMERS DE Growth rates of millennial cohort* • U.S. Medical Aesthetic industry is expected to grow at 9% through 2027, confirming historical trends Injectables is the fastest growth category at 10- 12% as new consumers enter the market for "preventative" treatments Injectables are drawing in younger consumers through "preventative" treatments and continue to grow quickly Purchasing power, resilience of spending * BCG, Medical Aesthetics Industry Outlook and BCG Credentials, December 2022 and company estimates 13
View entire presentation